Mutation analysis shows that the typical characteristic of PUC is gain-of-function mutations in oncogenes such as HRAS, FGFR3, and PI3K, while the typical characteristic of CIS is loss-of-function mutations affecting tumor suppressor genes such as TP53, RB1, and PTEN16,17. Here, RB1 is linked to in situ carcinoma.